HC Wainwright & Co. Reiterates Buy on Alpha Tau Medical, Maintains $9 Price Target
Portfolio Pulse from richadhand@benzinga.com
HC Wainwright & Co. analyst Yi Chen has reiterated a Buy rating on Alpha Tau Medical (NASDAQ:DRTS) and maintained a $9 price target.
May 24, 2023 | 1:54 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
HC Wainwright & Co. analyst Yi Chen reiterated a Buy rating on Alpha Tau Medical (NASDAQ:DRTS) and maintained a $9 price target.
The reiteration of a Buy rating and maintenance of a $9 price target by HC Wainwright & Co. analyst Yi Chen indicates a positive outlook for Alpha Tau Medical's stock. This news is likely to have a positive impact on the stock price in the short term as it shows confidence in the company's potential.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100